Skip Navigation
Skip to contents

대한신장학회

My KSN 메뉴 열기

간행물 검색
Urinary extracellular vesicle mirna profiling for detecting cardiac surgery-associated acute kidney injury
Pei Chun Fan
2023 ; 2023(1):
논문분류 :
춘계학술대회 초록집
Objectives: Cardiac surgery-associated acute kidney injury (CSA-AKI) is an important complication associated with poor short-term and long-term outcome, including chronic kidney disease even end stage kidney disease. This study analyzed the expression profile of miRNAs in urinary extracellular vesicles in patients with CSA-AKI. Methods: A total of 119 patients receivingcardiac surgery and admitted to the cardiac surgery intensive care unitwere enrolled from 2014 to 2019. The urine samples were collected 0 hour and 12 hours after surgery. In the discovery cohort, profiles of miRNA expression levels in urinary extracellular vesicles were assessed by next generation sequencing and then verified byreal-time quantitative RT-PCR analysis. MiRNAs candidates with altered expression between AKI and non-AKI groups were further analyzed.The score model based on miRNA expression was validated in the validation group.TargetScan 7.1 and miRDB databases were used for target prediction and KEGG was used for pathway analysis. Results: A total of 137 abundant miRNAs were identified in theurinary extracellular vesicles.There were29 significantly altered miRNAs found by MWU test.The score model, comprising three ratios (miR-21-5p/miR-204-5p, miR-21-5p/miR-10b-5p and miR-21-5p/miR-125a-5p), had a good performance in predicting development ofCSA-AKI (AUC 0.758, sensitivity 90.0%) and non-recovery of CSA-AKI (AUC 0.875, sensitivity 72.7%).Target prediction and pathway analysis revealed that the altered miRNAs were associated with HIF-1 signaling pathway. Conclusions: The score model derived by ratios ofurinary extracellular vesicularmiR-21-5p/miR-204-5p, miR-21-5p/miR-10b-5p and miR-21-5p/miR-125a-5pcanpredict development ofCSA-AKI and non-recovery of CSA-AKI.
위로가기

(06022) 서울시 강남구 압구정로 30길 23 미승빌딩 301호

Copyright© 대한신장학회. All rights reserved.